Drug-induced osteopathies: Drugs, pathogenesis, forms, diagnosis, prevention and therapy;Medikamenteninduzierte osteopathien : Medikamente, pathogenese, formen, diagnostik, prävention und therapie

Orthopade

Volumn 38, Issue 12, 2009, Pages 1245-1261

  Bartl, R ^a   Bartl, C ^b   Gradinger, R ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone metabolism; Drugs; Osteomalacia; Osteonecrosis; Osteoporosis

Indexed keywords

BONE DISEASES, METABOLIC; DRUG TOXICITY; HUMANS;

EID: 73649142724     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-009-1436-4     Document Type: Review

References (26)

1. Allport J (2008) Incidence and prevalence of medication-induced osteoporosis: evidence-based review. Curr Opin Rheumatol 20:435-441
2. Aspenberg P (2005) Drugs and fracture repair. Acta Orthop 76:741 -748
3. Bartl R (2006) Antiosteoporotika. Wissenschaftliche Verlagsgesellschaft, Stuttgart
4. Bartl R (2007) Antiepileptika-induzierte Osteopatie - Pathogenese, Prophylaxe, Früherkennung und Therapie. Dtsch Med Wochenschr 132:1475-1479
5. Bartl R(2008)Osteoporose-Prävention, Diagnostik, Therapie, 3. Aufl. Thieme, Stuttgart
6. Bartl R, Frisch B,Tresckow E von, Bartl C (2007) Bisphosphonates in medical practice. Springer, Berlin
7. Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809-1822
8. Borderi M, Farneti B.Tampellini L et al (2002) HIV-1, HAART and bone metabolism. New Microbiol 25:375-384
9. 9. Brown T, Qaqish R (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a metaanalytic review. AIDS 20:2165-2174 (Pubitemid 44684707)
10. Gage B, Birman-Deych E, Radford M et al (2006) Risk of osteoporotic fracture in elderly patients taking warfarin. Arch Intern Med 166:241-246
11. Kahn S, Haffner S, Heise M et al (2006) Glycemie durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427-2443
12. Knobel H,GuelarA,VallecilloG et al (2001) Osteopenia in HIV-infected patients? is it the disease or is it the treatment? AIDS 15:807-808
13. Marcus R (2008) Osteoporosis. Academic Press, San Diego
14. 14. Mezuk B, Eaton W, Golden S (2008) Depression and osteoporosis: epidemiology and potential mediating pathways. Osteoporos lnt 19:1-12 (Pubitemid 350198063)
15. MinkowitzB, Boskey A, Lane J et al (1991) Effects of propranolol on bone metabolism in the rat. J Orthop Res 9:869-875
16. Mori S (2003) Fracture healing with anti-resorptive agents. J Musculoskelet Neuronal Interact 3:314-316
17. Pack AM, Olarte LS, Morrell MJ et al (2003) Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 4:169-174
18. Petty SJ, O'Brian TJ, Wark JD (2007) Antiepileptic medication and bone health. Osteoporos lnt 18:129-142
19. Pilon D,CastillouxAM, Dorais M et al (2004) Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf 13:289-294
20. Richy F, Bousquet J, Eherlich G et al (2003) Inhaled corticosteroid effects on bone in asthmatic and COPD patients: a quantitative systematic study. Osteoporos lnt 14:179-190
21. SaagK, EmkeyR, Schnitzer T et al (1998) Alendronate for the treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292-299
22. Smith I, Dowsett M (2003) Aromatase inhibitors in breast cancer. N Engl J Med 348:2431-2442
23. 23. Smith M, Eastham J, Gleason D et al (2003) Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for non metastatic prostate cancer. J U rol 169:2008-2012 (Pubitemid 36576705)
24. Tebas P, Powderly W, Claxton S et al (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiviral therapy. AIDS 14F63-F67
25. Van Staa T, Leufkens H, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a metaanalysis. Osteoporos lnt 13:777-787
26. Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk - a metaanalysis. Acta Neurol Scand 112:277- 286